Borealis Ventures

The firm anchors its sourcing in the Dartmouth College research and alumni ecosystem, where it maintains deep ties. This academic affiliation provides access to faculty startups and spinouts that often fall outside the radar of larger, coastally concentrated venture funds. The firm supplements this pipeline with a transatlantic presence via its office in Vienna, Austria.

The separation allowed each team to pursue a more focused investment mandate. Building Ventures now independently runs the real-asset and construction-tech strategy, while Borealis concentrates entirely on therapeutic, digital-health, and animal-health companies. The transaction removed cross-sector distraction and gave Borealis a clearer identity as a pure healthcare investor.

Borealis presents itself as a venture capital firm rather than a single family office, despite having a closed, partnership-style structure. It does not publicly disclose its limited partners, making it difficult to determine definitively whether it represents a single family's capital. The firm raises funds and syndicates, which is more characteristic of a traditional venture manager than a single-family vehicle.

The firm identifies as a lifecycle investor, which means it deploys capital across multiple stages from seed to growth. Borealis works through syndicate partners to ensure companies have ongoing access to capital, suggesting it leads or co-leads rounds rather than making passive, small-ticket allocations. Specific check sizes are not publicly disclosed.

The firm is unusually hands-on for a venture investor, with a bench that includes venture fellows and consultants providing operational support. Avitide CEO Kevin Isett has publicly credited Phil Ferneau with a decade of active mentoring, calling it invaluable for navigating strategic inflection points. This operator-heavy model is a core part of the firm's value proposition to founders.